Jin Li

Title: Innovations of Inventor Jin Li

Introduction

Jin Li is a notable inventor based in Shoreview, MN (US). He has made significant contributions to the field of plant biotechnology, particularly in the development of methods for producing therapeutic polypeptides. With a total of 2 patents, his work has the potential to impact both human and animal health.

Latest Patents

Jin Li's latest patents include innovative methods for creating plants with specific genetic mutations. One of his patents focuses on a "Mutant plant or cell with reduced XylT and FucT." This patent provides materials and methods for making plants that are suitable for producing therapeutic polypeptides. These polypeptides are intended for administration to humans and animals, achieved through TAL effector endonuclease-induced mutations in genes encoding xylosyltransferases and fucosyltransferases. Another patent details a "Method for making Nicotiana plants with mutations in XylT and FucT alleles using rare-cutting endonucleases." This method also aims to produce plants capable of generating therapeutic polypeptides for similar applications.

Career Highlights

Throughout his career, Jin Li has worked with prominent companies in the biotechnology sector. Notable among these are Cellectis S.A. and Medicago Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative biotechnological solutions.

Collaborations

Jin Li has collaborated with several esteemed colleagues in his field, including Luc Mathis and Daniel F. Voytas. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Jin Li's contributions to plant biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications derived from plants.